Ian F. Smith, Director at ACORDA THERAPEUTICS INC (ACOR), sold 10,000 shares at $23.46 ($237K) on 2018-05-02, disclosed to the SEC on 2018-05-04.
Scheduled sale ($237k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.46 | 3,677 | $86K | 36.4% |
| 2 | $23.86 | 6,323 | $151K | 63.6% |
| Total | $23.71 avg | 10,000 | $237K | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |